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Summary
 
The potential involvement of early growth response (Egr)-1, a zinc-finger transcription factor
belonging to the immediate-early genes, in positive/negative selection of thymocytes has been
implicated by its expression in the population of CD4
 
1
 
CD8
 
1
 
 double positive (DP) cells under-
going selection. To further investigate this possibility, transgenic mice overexpressing Egr-1 in
thymocytes were bred with a transgenic mouse line expressing a T cell receptor (TCR) recog-
nizing the H-Y male antigen in the context of H-2
 
b
 
 class I major histocompatibility complex
(MHC) molecules. In Egr-1/TCR H-Y double-transgenic mice, efficient positive selection of
H-Y CD8
 
1
 
 T cells occurred, even in mice on either a nonselecting H-2
 
d
 
 background or a 
 
b
 
2-
microglobulin (
 
b
 
2m)-deficient background in which the expression of class I MHC heavy
chains is extremely low; no positive selection was observed on a K
 
b
 
2
 
/
 
2
 
D
 
b
 
2
 
/
 
2
 
b
 
2m
 
2
 
/
 
2
 
 back-
ground where class I MHC expression is entirely absent. Similarly, when the Egr-1 transgene
was introduced into a class II MHC–restricted TCR transgenic mouse line, Egr-1/TCR dou-
ble-transgenic mice revealed increased numbers of CD4
 
1
 
 T cells selected by class II MHC, as
well as significant numbers of CD8
 
1
 
 T cells selected by class I MHC (for which the transgenic
TCR might have weak affinity). Thus, Egr-1 overexpression allows positive selection of thy-
mocytes via TCR–MHC interactions of unusually low avidity, possibly by lowering the
threshold of avidity required for positive selection. Supporting this possibility, increased num-
bers of alloreactive T cells were positively selected in Egr-1 transgenic mice, resulting in a strik-
ingly enhanced response against allo-MHC. These results suggest that expression of Egr-1 and/or
its target gene(s) may directly influence the thresholds required for thymocyte selection.
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P
 
ositive/negative selection of thymocytes at the
CD4
 
1
 
CD8
 
1
 
 double positive (DP)
 
1
 
 stage is the key
checkpoint for thymocyte maturation, at which their
fate—whether they develop further to CD4
 
1 
 
or CD8
 
1
 
 sin-
gle positive (SP) cells or die by clonal deletion—is decided
(1, 2). Accumulating evidence indicates that the avidity be-
tween T cell receptors (TCRs) expressed on thymocytes
and MHC/antigen-peptide complexes displayed on the
surface of APCs appears to define the type of intracellular
signals generated, which promote thymocytes to be either
positively selected (further developing to the SP stage) or
negatively selected (clonally deleted); avidity is dependent
on TCR–MHC affinity and the expression levels of both
complexes (3, 4). It is believed that there are thresholds in
the strength of TCR–MHC avidity that determine the na-
ture and consequences of subsequent TCR signaling (3, 4).
When thymocytes and APCs interact with high avidity,
cells are negatively selected through the apoptotic pathway,
whereas thymocytes are promoted to the SP cell stage
when the avidity is moderate but sufficient. If the avidity is
too low, cells cannot undergo either type of selection, re-
sulting in their death as “neglected cells.” However, the
molecular mechanism that defines these thresholds for se-
lection events is unclear.
Signals generated during positive/negative selection must
be differentially controlled; hence, rapidly responding tran-
scriptional regulators able to elicit a cascade of changes in
gene expression should be important. Immediate-early genes,
expression of which is rapidly induced after cell-surface
receptor ligation without de novo
 
 
 
protein synthesis, are
strong candidates for such a rapid response mediator (5).
 
1
 
Abbreviations used in this paper:
 
 DP, double positive; Egr-1, early growth
response 1; Egr/H-Y, Egr-1 transgene–positive H-Y transgenic; I
 
0
 
, class I
MHC–deficient; II
 
0
 
, class II MHC–deficient; ISP, immature SP; NL/H-Y,
Egr-1 transgene–negative H-Y transgenic; PNAr, peanut agglutinin recep-
tor; RAG, recombination-activating gene; SP, single positive; TG, trans-
genic.
 
This document was created with FrameMaker 4.0.4 
716
 
Altered Thymic Selection in Egr-1 Transgenic Mice
 
Shao et al. reported recently that the expression of one of
these immediate-early genes, early growth response (Egr)-1,
a zinc-finger transcription factor rapidly induced by TCR
ligation, appears to correlate with selection events, as it is
expressed at much lower levels in DP cells from mutant
mice deficient for both MHC class I and class II molecules
than in DP cells from wild-type mice. In addition, Egr-1
expression in the mutant DP cells was able to be upregu-
lated by anti-CD3 mAb ligation (6).
We recently generated transgenic mouse lines over-
expressing Egr-1 in thymocytes under the control of the
lck-proximal promoter (7), and showed that in Egr-1 trans-
genic mice on a recombination-activating gene (RAG)-
deficient background, thymocytes bypassed the block at the
CD25
 
1
 
CD44
 
2
 
 DN stage and matured to the immature
single positive (ISP) cell stage. Here, the effect of Egr-1 ex-
pression on positive/negative selection is extensively ana-
lyzed by breeding Egr-1 transgenic mice with various
TCR transgenic mice, as well as by evaluating positive se-
lection of alloreactive T cells in Egr-1 transgenic mice.
This report provides interesting insight into what is actually
required for positive selection and what transcriptional
pathways may be involved in the selection events.
 
Materials and Methods
 
Mice.
 
All mice used here were maintained in the specific
pathogen–free facility of the Basel Institute for Immunology.
Matched sets of littermates with transgene-positive and -negative
genotypes were used in all experiments.
 
Serological Reagents and Flow Cytometry.
 
Reagents used for stain-
ing T cells and subsets thereof were as described (7–9, and refer-
ences therein). Thymus, lymph node, and spleen cells were
stained with saturating levels of mAbs and analyzed using a FACS-
Calibur
 
Ò
 
 cytometer (Becton Dickinson, San Jose, CA).
 
Cell Survival Assay.
 
H-Y CD8
 
1
 
 SP cells were sorted after
staining thymocytes for CD4, CD8, T3.70, and peanut agglutinin
receptor (PNAr). 5 
 
3
 
 10
 
5
 
 cells from each type of mice were cul-
tured in triplicate in 96-well flat-bottomed microculture plates in
complete DMEM culture medium including 10% FCS. 24, 48,
72, 96, and 120 h after starting the culture, the number of living
cells was evaluated by trypan blue exclusion and plotted as a sur-
vival curve. H-Y CD8
 
1
 
 SP cells from all types of mice showed a
similar number of living cells at each time point.
 
Purification of CD8
 
1
 
 T Cells.
 
CD8
 
1
 
 T cells were purified by
incubating spleen cells for 30 min on ice with 10% (vol/vol) cul-
ture supernatant of hybridomas RL172 (IgM antibody to CD4)
and M5/114 (antibody to class II MHC), washed, and then incu-
bated for an additional 1 h at 37
 
8
 
C in 10% Lo-Tox complement
(Cedarlane Labs Ltd., Hornby, Ontario, Canada). Dead cells were
excluded by Ficoll gradation. Living cells were washed twice and
resuspended in complete DMEM.
 
T Cell Proliferation Assay.
 
Purified CD8
 
1
 
 T cells (5 
 
3
 
 10
 
5
 
/
well) were cultured in the presence of various concentrations of
either immobilized anti-CD3 mAb (KT-3; provided by Dr. C.
Benoist, Strasbourg, France) or Con A (Sigma Chemical Co., St.
Louis, MO). The KT-3 mAb was immobilized by preincubation
of wells at 4
 
8
 
C overnight. All cultures were performed for 3 d,
and proliferation was assessed by [
 
3
 
H]thymidine incorporation in
the last 16 h of culture.
 
In Vivo and In Vitro Recognition of H-Y Antigen.
 
This is a mod-
ification of a similar experiment described elsewhere (10). In
brief, purified CD8
 
1
 
 T cells including 2 
 
3
 
 10
 
6
 
 H-Y CD8
 
1
 
 T cells
calculated by the percentage of T3.70
 
1
 
 
 
population in the CD8
 
1
 
cells after fluorocytometric analysis, were suspended in 200 
 
m
 
l of
PBS, and injected intravenously into 6–8-wk-old male and fe-
male C
 
a
 
-deficient mice. In one experiment, cells from each type
of donor mouse were injected into two pairs of male and female
recipient mice. 4 d after injection, spleen cell suspension from
each recipient was stained for CD8 and T3.70, and analyzed by
FACScan
 
Ò
 
 (Becton Dickinson). Absolute number of H-Y CD8
 
1
 
T cells was calculated from spleen cell number and percentage of
CD8
 
1
 
T3.70
 
1
 
 cell population. For the in vitro proliferation assay,
purified CD8
 
1
 
 T cells from each type of mouse, including vari-
ous numbers of H-Y CD8
 
1
 
 T cells, were stimulated by 8 
 
3
 
 10
 
5
 
/
well of 3,000-rad irradiated spleen cells from male or female B6
mice in complete DMEM in 96-well microculture plates. Cul-
tures were performed for 5 d, and proliferation was assessed by
[
 
3
 
H]thymidine incorporation in the last 16 h of culture.
 
MLRs.
 
Responders (B cell–depleted lymph node cells) were
cultured with stimulators (3,000-rad irradiated spleen cells) at var-
ious ratios for 5 d in complete DMEM in flat-bottomed 96-well
microculture plates. Proliferation was assessed by [
 
3
 
H]thymidine
incorporation in the last 16 h of culture.
 
Bone Marrow Chimeras.
 
To construct bone marrow chimeras,
recipient mice were 10-Gy (from a cobalt source) irradiated. 24 h
later, they were injected intravenously with 10
 
7
 
 bone marrow
cells from which mature T and B cells had been depleted by
treatment with anti-CD4 (RL172) and anti-CD8 (31M) mAbs
plus Lo-Tox complement (Cedarlane Labs Ltd.). After grafting,
mice were rested for 5 wk to allow reconstitution before analysis.
 
Results
 
Efficient Positive Selection of H-Y CD8
 
1
 
 T Cells by Low
Avidity TCR–MHC Interactions in the Presence of Egr-1 Over-
expression.
 
As described in our previous report, Egr-1
transgenic mice (Egr-1–TG) exhibit transgene expression at
levels far exceeding endogenous Egr-1, when analyzed by
Northern blotting using thymic RNA from transgenic and
negative littermate mice (7). As observed for many other
transgenes driven by the lck-proximal promoter (11), Egr-1
transgene expression was detected in a wide range of devel-
opmental stages of thymocytes of Egr-1–TG, including DP
cells, when analyzed by the reverse transcription PCR
method (12) using RNA from sorted cells from each popu-
lation (data not shown). No obvious transgene expression
was detected either in spleen or lymph node by Northern
blot analysis, indicating thymocyte-specific transgene ex-
pression (7).
To assess the possible effect of Egr-1 expression on thy-
mocyte selection, Egr-1–TG were cross-bred with trans-
genic mice expressing a TCR recognizing the H-Y male
antigen in the context of H-2
 
b
 
 class I, D
 
b
 
 molecules. It is
well-established that thymocytes expressing H-Y–specific
 
ab
 
 TCRs are positively selected in female H-2
 
b/b
 
 mice and
negatively selected in male H-2
 
b/b
 
 mice, but do not un-
dergo either positive or negative selection in female or
male mice on an H-2
 
d/d
 
 background (8, 13). Fig. 1 
 
a
 
 shows
CD4/CD8 profiles of mature thymocytes bearing the H-Y 
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TCR defined as T3.70 (mAb against H-Y TCR 
 
a
 
 chain)
 
high
 
,
PNAr
 
low
 
. As shown in the upper panels, in H-2
 
b/b
 
 females,
both Egr-1-TG with an H-Y TCR transgene (Egr/H-Y)
and Egr-1–TG-negative littermate mice with an H-Y
TCR transgene (NL/H-Y) harbored mature H-Y CD8
 
1
 
SP thymocytes. The CD8
 
1
 
 SP cells in these profiles do not
contain immature CD8 SPs (ISPs), which exhibit high lev-
els of PNAr (7). However, in H-Y mice, since expression
levels of transgenic H-Y TCR in DN cells (which are
PNAr
 
low
 
) are as high as those in mature SP cells (8), a sig-
nificant proportion of DN cells as well as mature SP cells
are plotted in these profiles. The numbers of total thymocytes
were slightly larger in Egr/H-Y mice than in NL/H-Y
mice (Table 1). However, the absolute numbers of mature
H-Y CD8
 
1
 
 SP cells were 
 
z
 
1.7 times higher in Egr/H-Y
than in NL/H-Y mice (Table 1). In line with this, the per-
centages of T cells bearing the transgenic 
 
a
 
 chain (T3.70
 
1
 
)
in the DP and the total mature CD8
 
1
 
 populations were
larger in Egr/H-Y than in NL/H-Y mice (Table 1). Thus,
H-Y CD8
 
1
 
 T cells appear to be more efficiently positively
selected in the presence of Egr-1 overexpression. More
surprisingly, significant numbers of mature H-Y CD8
 
1
 
 SP
thymocytes were also observed in female Egr/H-Y mice
on either a nonselecting H-2
 
d/d
 
 background or a 
 
b
 
2m-defi-
cient (
 
b
 
2m
 
0
 
) H-2
 
b/b
 
 background (14, 15), in which class I
MHC heavy chains are expressed at extremely low levels
(Fig. 1 
 
a
 
, 
 
middle
 
 and 
 
bottom
 
; absolute numbers of both total
thymocytes and mature H-Y CD8
 
1
 
 SP cells are shown in
Table 1). Very few (
 
,
 
5 
 
3
 
 10
 
3
 
) mature H-Y CD8
 
1
 
 SP cells
were detected in NL/H-Y mice on both H-2
 
d/d
 
 and 
 
b
 
2m
 
0
 
backgrounds.
H-Y CD8
 
1
 
 T cells were observed in peripheral lym-
phoid tissues in Egr/H-Y mice on H-2
 
b/b
 
, H-2
 
d/d
 
, and
 
b
 
2m
 
0
 
 backgrounds as well as in H-2
 
b/b
 
 NL/H-Y female
mice (numbers shown in Table 1). As observed in the thy-
mus, the percentage of T cells bearing the transgenic 
 
a
 
chain (T3.70
 
1
 
) in splenic CD8
 
1
 
 cells was larger in H-2
 
b/b
 
Egr/H-Y mice than in H-2
 
b/b
 
 NL/H-Y mice (Table 1).
Figure 1. (a) Thymocyte suspensions from female Egr/H-Y and NL/H-Y mice on H-2b/b, H-2d/d, or b2m0 background were stained for CD4, CD8,
H-Y transgenic a chain (T3.70), and PNAr, and analyzed by flow cytometry. CD4/CD8 plots of T3.70high, PNArlow cells are shown. The averages of the
absolute numbers of mature H-Y CD81 SP cells (T3.70high, PNArlow) of each type of mice are indicated in each panel. Five pairs of female Egr/TG and
NL/H-Y mice of each background were examined. (b) CD4/CD8 plots of T3.70high, PNArlow thymocytes from female I0b2m0 recipient mice into
which female b2m0 Egr/H-Y bone marrow cells (BM) or female b2m0 NL/H-Y bone marrow cells were transplanted (left panels). Right, The same pro-
file of female b2m0 recipient mice into which female b2m0 Egr/H-Y bone marrow cells were grafted. The averages of the absolute numbers of mature
H-Y CD81 SP cells (T3.70high, PNArlow) from two sets of transfer experiments are indicated in each panel. (c) CD4/CD8 plots of T3.70high, PNArlow thy-
mocytes from b2m0 or b2m0II0 Egr/H-Y mice. The averages of the absolute numbers of mature H-Y CD81 SP cells (T3.70high, PNArlow) of each type of
mouse are indicated in each panel. Three pairs of female b2m0 and b2m0II0 Egr/H-Y mice were examined.
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Peripheral H-Y CD81 T cells revealed similar expression
patterns of several activation and memory markers such as
CD25, CD44, and Mel-14 in all types of mice (data not
shown).
Thus, in the presence of Egr-1 overexpression, H-Y
thymocytes appear to be efficiently positively selected even
by H-2d class I molecules and by the extremely low levels
of class I expressed in the absence of b2m, and mature to
become peripheral H-Y CD81 T cells.
Whether positive selection of H-Y CD81 T cells can
occur in the complete absence of class I MHC molecules
was assessed by grafting bone marrow cells from female
b2m0 Egr/H-Y (H-2b/b) mice into female Kb2/2Db2/2
b2m2/2 (I0b2m0; H-2b/b) recipient mice, which com-
pletely lack class I MHC (16, 17). As shown in Fig. 1 b, no
mature H-Y CD81 SP thymocytes could be observed in
the thymi from I0b2m0 recipients into which either b2m0
Egr/H-Y or b2m0 NL/H-Y bone marrow cells were
transplanted. In contrast, female b2m0 (H-2b/b) recipients
into which b2m0 Egr/H-Y bone marrow cells had been
transferred harbored a significant number (6.2 6 0.6 3 106;
n 5 2) of mature H-Y CD81 SP thymocytes. This result
strongly indicates that H-Y CD81 T cells in H-2d/d and
b2m0 Egr/H-Y mice were positively selected by H-2d class
I molecules or by the extremely low levels of class I ex-
pressed in the absence of b2m, but not by other molecules
like class II MHC. This was supported by the analysis of
b2m, class II MHC doubly deficient (b2m0II0) Egr/H-Y
mice, which harbored grossly the same numbers of mature
H-Y CD81 SP thymocytes as b2m0 Egr/H-Y mice (Fig. 1 c).
H-Y CD81 T cells Selected by Low Avidity TCR–MHC
Interactions Are Entirely Functional. Whether H-Y CD81
T cells from H-2b/b, H-2d/d, and b2m0 Egr/H-Y mice
were functional was determined using matched cells from
H-2b/b female NL/H-Y mice as controls. First, purified
CD81 T cells from each type of mouse were stimulated by
anti-CD3 mAb or Con A. As shown in Fig. 2, a and b,
CD81 T cells from Egr/H-Y mice on all three back-
grounds responded to both anti-CD3 mAb and Con A to a
comparable degree as those from H-2b/b female NL/H-Y
mice.
Next, to determine whether the H-Y CD81 T cells spe-
cifically recognize the H-Y male antigen, equal numbers of
H-Y CD81 T cells from each type of mouse were injected
intravenously into either male or female H-2b/b Ca-defi-
cient mice (which lack T cells; reference 18), and the num-
ber of H-Y CD81 T cells in recipient spleens was evaluated
4 d after injection. As shown in Fig. 2 c, significant num-
bers of H-Y CD81 T cells were detected in male recipients
into which either Egr/H-Y or NL/H-Y T cells were trans-
planted. In contrast, no obvious H-Y CD81 T cells were
detected in female recipients. These results suggest that
H-Y CD81 T cells from all types of mice recognized and
specifically responded to the male antigen; expansion of the
H-Y CD81 T cells resulted in accumulation of a significant
population of those T cells in recipient spleens. Interest-
ingly, the number of H-Y CD81 T cells in male recipients
into which cells from b2m0 Egr/H-Y mice were injected
was slightly lower (z30% less) than those in recipients into
which cells from other types of mice were injected. This
may be due to rejection by NK cells, since NK cells recog-
nize and kill b2m0 T cell blasts because of their extremely
low class I MHC expression (19, 20). Supporting this possi-
bility, the in vitro response of H-Y CD81 T cells from
b2m0 Egr/H-Y mice to irradiated spleen cells from male
C57BL/6 (B6: H-2b/b) mice (containing NK cells that are
no longer able to kill target cells due to irradiation) was
comparable to the response of H-Y CD81 cells from other
types of mice (Fig. 2 d). As observed in in vivo experi-
ments, cells from all types of mice also failed to respond to
female spleen cells in vitro.
Thus, the H-Y CD81 T cells positively selected by low
avidity ligands in H-2d/d or b2m0 Egr/H-Y mice were
functionally indistinguishable from cells positively selected
Table 1. Positive Selection of H-Y CD8 T Cells
Mice
Absolute number (3 1027) % of T3.701 cells in:
Total H-Y CD81 DP Total CD81
Thymus NL/H-Y (b/b) 7.1 6 0.2 1.4 6 0.3 33 6 2.5 82 6 3.4
Egr/H-Y (b/b) 8.0 6 0.2 2.6 6 0.2 62 6 6.2 90 6 2.4
Egr/H-Y (d/d) 7.0 6 0.4 1.0 6 0.1 ND ND
Egr/H-Y (b2m0) 7.2 6 0.1 0.9 6 0.2 ND ND
Spleen NL/H-Y (b/b) 0.9 6 0.1 52 6 5.3
Egr/H-Y (b/b) 1.5 6 0.3 85 6 3.5
Egr/H-Y (d/d) 1.6 6 0.4 ND
Egr/H-Y (b2m0) 1.4 6 0.2 ND
Absolute numbers of total thymocytes and mature H-Y CD81 T cells are shown. Percentages of T3.701 population in DP or total mature CD81
cells in the thymus and spleen are also presented. Each value represents the mean of data compiled from five mice 6 SD.719 Miyazaki and Lemonnier
in NL/H-Y female H-2b/b mice in the absence of the Egr-1
transgene.
More Efficient Negative Selection in Egr-1 Transgenic Mice.
In male H-2b/b thymi, H-Y thymocytes are negatively se-
lected and die through the apoptotic pathway (8). As
shown in Fig. 3, both Egr/H-Y and NL/H-Y thymocytes
have undergone clonal deletion. Interestingly, even more
efficient negative selection appears to occur in Egr/H-Y
mice, judging from the lower number of thymocytes in
Egr/H-Y mice. However, male H-2d/d and b2m0 Egr/H-Y
mice exhibited positive selection of H-Y CD81 SP cells,
and the numbers of mature H-Y CD81 SP cells were com-
parable to those of females (data not shown).
Positive Selection of AND-TCR T Cells in the Presence of
Egr-1 Overexpression. Egr-1 transgenic mice were also
bred with another type of transgenic mouse expressing a
TCR recognizing the moth cytochrome C peptide in the
context of class II MHC I-Ek (called AND mice; reference
9). The AND TCR has a weak affinity for I-Ab class II
MHC molecules, and therefore, CD41 SP thymocytes are
positively selected in an H-2b/b background (9, 21). The
upper panels of Fig. 4 show the CD4/CD8 profiles of ma-
ture thymocytes bearing the AND TCR (defined as trans-
genic TCR [Vb3]high, PNArlow) from Egr-1 transgene–pos-
itive AND mice (Egr/AND) and Egr-1 transgene–negative
AND mice (NL/AND), both of which are on an H-2b/b
background. Egr/AND mice contained increased numbers
of both total thymocytes (1.1 6 0.1 3 108 in Egr/AND
versus 0.8 6 0.2 3 108 in NL/AND; n 5 4 each) and
AND CD41 SP thymocytes (3.5 6 0.3 3 107 in Egr/
AND versus 2.2 6 0.3 3 107 in NL/AND; n 5 4 each).
This is reminiscent of the increased numbers of H-Y CD81
SP cells in H-2b/b Egr/H-Y mice and, again, suggests more
efficient positive selection in the presence of the Egr-1
transgene. Interestingly, a significant number (8.0 6 0.6 3
105; n 5 4) of mature AND CD81 SP cells were observed
Figure 2. (a and b) CD81 lymph node T cells were purified from fe-
male Egr/H-Y mice (Egr) on H-2b/b, H-2d/d, and b2m0 backgrounds and
from female NL/H-Y mice (NL) on H-2b/b by depleting CD41 cells and
class II MHC–positive cells. Cells were stimulated by culture with (a) im-
mobilized anti-CD3 mAb or (b) Con A. In both experiments, prolifera-
tion was assessed in duplicate samples by [3H]thymidine incorporation.
Data are representative of four independent experiments. (c) Purified
CD81 T cells including 5 3 106 H-Y CD81 cells in PBS were injected
intravenously into male or female Ca2/2 recipient mice. 4 d after injec-
tion, the numbers of H-Y CD81 cells in recipient spleens were evaluated
and are represented by bars 6 SD. Three sets of independent experiments
were performed. Numbers of H-Y CD81 cells in female recipients were
identical or less than those of mice with no cells injected [donor (2)],
which is indicative of background in the fluorocytometric analysis. (d)
Purified CD81 T cells including the indicated numbers of H-Y CD81
cells were stimulated by 3,000-rad irradiated spleen cells from male or fe-
male B6 mice. Proliferation was assessed by duplicate [3H]thymidine in-
corporation. Results are representative of three sets of independent exper-
iments; all experiments showed similar results. Figure 3. CD4/CD8 profiles of thymocytes from male Egr/H-Y and
NL/H-Y mice on an H-2b/b background, gated on T3.701 cells. Num-
bers in the profiles indicate the averages of the absolute cell numbers of
positive cells within a quadrant, of all mice analyzed. Total thymocyte
numbers for both types of mice are shown. Three pairs of male Egr/H-Y
and NL/H-Y mice were analyzed.720 Altered Thymic Selection in Egr-1 Transgenic Mice
in Egr/AND mice. It is possible that the AND TCR also
has a weak affinity for class I MHC (22) which is not nor-
mally sufficient to induce signal(s) for positive selection.
Egr-1 overexpression might lower the threshold for posi-
tive selection, resulting in positive selection of AND cells
by class I MHC, creating a population of AND CD81 SP
cells. This hypothesis is well-supported by analysis of Egr/
AND mice on a b2m0 background, where the number of
AND CD81 SP cells strikingly decreased (Fig. 4, middle).
However, the difference between H-Y CD81 SP cells and
AND CD81 SP cells in b2m0 Egr-1 transgenic mice is in-
triguing; very efficient positive selection of H-Y CD81 SP
cells was observed, while almost no positive selection of
AND CD81 SP cells was achieved, in the b2m0 back-
ground. This may be explained by a possible difference in
the original affinity of H-Y TCR and AND TCR for class I
MHC molecules. The former may have a relatively high
affinity, which creates sufficient avidity for positive selection
even with extremely low expression levels of class I MHC,
when Egr-1 overexpression lowers the threshold. In con-
trast, the latter may have a low affinity, which contributes to
sufficient avidity with normal expression levels of class I
MHC in the presence of Egr-1 overexpression, but not with
the extremely low levels of class I MHC in b2m0 mice.
In a class II MHC–deficient (II0) background, in which
“leaky” expression of class II molecules is not detected
(23), AND CD41 cells virtually disappeared in both Egr/
AND and NL/AND mice (Fig. 4, bottom). This is consis-
tent with failed positive selection of H-Y CD81 T cells on
an I0b2m0 background, which entirely lacks class I MHC
expression. Deficiency of positive selection in the complete
absence of MHC molecules indicates a requirement of
TCR-mediated signaling to promote DP cells to the SP
stage, even in the presence of Egr-1 overexpression.
Increased Frequency of Alloreactive T Cells in Egr-1 Trans-
genic Mice. Alloreactive T cells, which recognize allo-MHC
complexes, are believed to be positively selected by auto-
MHC/antigen-peptide complexes for which the alloreac-
tive TCRs have sufficient, but not too much, avidity (24).
Therefore, whether Egr-1 expression might affect the se-
lection of alloreactive T cells was determined using “nor-
mal” (no TCR transgenes introduced) Egr-1 transgenic
mice. Fig. 5 a demonstrates allo-MLR responses of H-2b/b
Egr-1–TG and NL mice to bm12 (H-2b with a mutated
class II) and BALB/c (H-2d/d) spleen cells. Transgenic T
cells exhibited enhanced responses to both bm12 and
BALB/c spleen cells. Similar enhanced allo-responses of
H-2d/d transgenic T cells were elicited towards B6 (H-2b/b)
spleen cells (Fig. 5 b). These enhanced allo-responses of
transgenic T cells appear to be due to an increased fre-
quency of alloreactive T cells, but not to hyperproliferation
of each T cell, because fewer transgenic T cells responded
to the stimulators, as shown by the limiting dilution of re-
sponding cells in Fig. 5, a and b; and transgenic and nega-
tive littermate T cells exhibited comparable proliferative
responses to Con A (Fig. 5 c). Overall, Egr-1 overexpres-
sion appears to allow positive selection of a larger number
of alloreactive T cells, some of which originally might not
have had sufficient affinity with the auto-MHC to be posi-
tively selected in normal mice.
Discussion
This is the first description of a transcription factor be-
having as a modulator of positive selection; Egr-1 overex-
pression allows positive selection of thymocytes mediated
by low avidity interactions with ligand(s) that are usually
not sufficient, perhaps by lowering the threshold of avidity
required for positive selection.
One might argue that Egr-1 overexpression induces sur-
vival effectors, such as antiapoptotic factors (25–30) in thy-
mocytes. This may result in accumulation of the few leaky
mature SP cells, such as the very small number of H-Y
CD81 SP cells that are detectable in both H-2d/d and b2m0
NL/H-Y mice, thus forming a seemingly positively se-
lected cell population. However, this is unlikely for at least
three reasons. First, purified H-Y CD81 SP cells from
H-2b/b, H-2d/d, or b2m0 female Egr/H-Y mice and H-2b/b
female NL/H-Y mice showed comparable survival curves
Figure 4. Thymocyte suspensions from Egr/AND and NL/AND mice
on either H-2b/b, b2m0, or class II MHC–deficient (IIo) backgrounds
were stained for CD4, CD8, AND transgenic b chain (Vb3), and PNAr,
and analyzed by flow cytometry. CD4/CD8 plots of cells gated on
Vb3high, PNArlow are shown. Numbers in the profiles indicate the aver-
ages of the absolute cell numbers of positive cells within a quadrant.
N.D., No cell detectable.721 Miyazaki and Lemonnier
when cells were simply cultured in vitro (data not shown;
see Materials and Methods). Second, I0b2m0 recipient mice
into which b2m0 Egr/H-Y bone marrow cells were trans-
planted did not harbor the significant H-Y CD81 SP cell
population that was seen in H-2d/d or b2m0 female Egr/
H-Y mice, although their thymi contained detectable leaky
H-Y CD81 SP cells. Third, both male H-2b/b Egr/H-Y
and NL/H-Y thymocytes exhibited clonal deletion of H-Y
cells, indicating no rescue from apoptosis of Egr/H-Y cells
undergoing negative selection. On the contrary, even more
efficient negative selection appears to occur in Egr/H-Y
mice. By these criteria, Egr-1 overexpression does not ap-
pear to induce survival effectors for thymocytes. It seems
more likely that Egr-1 overexpression allows an unusually
low avidity interaction between TCR and MHC/antigen-
peptide complexes to initiate positive selection and further
development of thymocytes.
An alternative argument is that Egr-1 overexpression itself
might be sufficient to promote the DP to SP transition, with
no interaction between thymocytes and ligands required.
When the Egr-1 transgene was introduced into a RAG-defi-
cient background, thymocytes did overcome the “b selec-
tion” beyond the maturation block at the CD251CD442
DN stage and developed into immature CD8 single posi-
tive (ISP) cells without any signaling through the TCR (7).
However, this was not the case for positive selection at the
DP stage. As we demonstrated in a previous report, al-
though irradiated Egr-1 transgenic mice on a RAG-defi-
cient background developed DP cells expressing the Egr-1
transgene but lacking TCR expression, neither CD41 nor
CD81 SP cells were observed (7). This suggests that DP
cells do require some interaction with ligand(s) to proceed
to the SP stage even in the presence of Egr-1 overexpres-
sion. This is supported convincingly by the analysis of
I0b2m0 recipient mice into which b2m0 Egr/H-Y bone
marrow cells were transplanted, in which no positive selec-
tion of H-Y CD81 T cells occurred, as well as of Egr/
AND mice on a class II MHC–deficient background,
which harbored no AND CD41 T cells. Hence, Egr-1 ex-
pression appears not to directly initiate transition of DP
cells to the SP stage, but may influence the threshold of
avidity required for positive selection.
Functions of T cells selected by unusually low avidity
TCR–MHC interactions in the presence of Egr-1 overex-
pression appear normal both in responses to various stimuli
and in specificity of antigen-peptide recognition, as dem-
onstrated by the functional analysis of mature H-Y CD81
T cells in H-2d/d and b2m0 Egr/H-Y mice. However,
long-term survival of a naive population of peripheral H-Y
CD81 T cells in H-2d/d Egr/H-Y mice could be affected,
as a recent report by Tanchot et al. (16) implicated a re-
quirement of the right MHC for survival of peripheral na-
ive T cells. Therefore, a large proportion of peripheral H-Y
CD81 T cells in H-2d/d Egr/H-Y mice might be newly
generated T cells. Tanchot et al. also demonstrated a re-
quirement of only a nonspecific class I MHC for survival of
peripheral memory T cells (16). This is consistent with the
comparable expression patterns of memory markers such as
Mel-14 in the peripheral H-Y CD81 T cells in H-2d/d
Egr/H-Y mice and H-2b/b NL/H-Y mice.
Phenotype in Egr-1 transgenic mice indicates a physio-
logical role of Egr-1 in determining the threshold required
Figure 5. (a) MLR responders were titrated B cell–depleted lymph node
cells from either Egr-1 transgenic (TG) or negative littermate (NL) mice, both
with an H-2b/b background, stimulated with 3,000-rad irradiated 5 3 105
spleen cells from bm12 (H-2b with a mutated class II MHC), BALB/c (H-2d),
or autologous spleen cells. (b) MLR was performed as above, with H-2d/d re-
sponder T cells and B6 (H-2b) stimulator cells. The smallest number of responder
cells at which [3H]thymidine incorporation was detected in transgenic T cells (rect-
angle) and in negative littermate T cells (ellipse) in each panel is indicated. All ex-
periments were repeated with four pairs of Egr-1 transgenic and negative litter-
mate mice. In all panels, each value represents the mean of all results 6 SD. (c)
5 3 105 B cell–depleted lymph node cells from transgenic (TG) and negative
littermate (NL) mice were stimulated by 1 mg/ml of Con A for 72 h. Prolifera-
tion was assessed by duplicate [3H]thymidine incorporation for the last 16 h.
Bars represent the mean of all results of three independent experiments 6 SD.722 Altered Thymic Selection in Egr-1 Transgenic Mice
for positive selection. Perhaps related to this, Egr-1 overex-
pression may also affect negative selection. As described
above, more efficient negative selection appeared to be
achieved by Egr-1 overexpression in male H-2b/b H-Y
mice. However, thymocytes express other members of Egr
family genes, such as Egr-2, -3, and -4, all of which share a
highly conserved DNA-binding domain (5, 6). These
members might functionally compensate for each other,
and hence no alteration of thymic selection is observed in
Egr-1–deficient mice as discussed previously (7, 31). There-
fore, a set of genes controlled by a common binding site for
Egr genes, including Egr-1, might be critical in defining
the overall thresholds required for thymic selection. Fur-
ther characterization of Egr target genes should shed light
on the precise molecular mechanism underlying the posi-
tive/negative selection of thymocytes.
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